| (12) International Application Status Report | ||
|
|
||
| Received at International Bureau: 08 April 2020 (08.04.2020) | ||
|
|
||
| Information valid as of: 16 October 2020 (16.10.2020) | ||
|
|
||
| Report generated on: 25 January 2021 (25.01.2021) | ||
|
|
||
| (10) Publication number: | (43) Publication date: | (26) Publication language: |
| WO 2020/203792 | 08 October 2020 (08.10.2020) | Japanese (JA) |
|
|
||
| (21) Application number: | (22) Filing date: | (25) Filing language: |
| PCT/JP2020/014079 | 27 March 2020 (27.03.2020) | Japanese (JA) |
|
|
||
| (31) Priority number(s): | (32) Priority date(s): | (33) Priority status: |
| 2019-065398 (JP) | 29 March 2019 (29.03.2019) | Priority document received (in compliance with PCT Rule 17.1) |
|
|
||
| (51) International Patent Classification: | ||
| A61P 21/00 (2006.01); A61P 21/06 (2006.01); A23L 33/135 (2016.01); A61K 35/745 (2015.01) | ||
|
|
||
| (71) Applicant(s): | ||
| MORINAGA MILK INDUSTRY CO., LTD.
[JP/JP]; 33-1, Shiba 5-chome, Minato-ku, Tokyo
1088384 (JP) (for all designated states)
|
||
|
|
||
| (72) Inventor(s): | ||
| TODA, Kazuya; c/o MORINAGA MILK INDUSTRY CO., LTD., 1-83, Higashihara 5-chome, Zama-shi, Kanagawa
2528583
(JP)
|
||
|
|
||
| (74) Agent(s): | ||
| IP FIRM SHUWA; Acropolis 21 Building 8th floor, 4-10, Higashi Nihonbashi 3-chome, Chuo-ku, Tokyo
1030004 (JP)
|
||
|
|
||
| (54) Title (EN): COMPOSITION FOR CONVERTING SKELETAL MUSCLE TO SLOW MUSCLE | ||
| (54) Title (FR): COMPOSITION DESTINÉE À CONVERTIR UN MUSCLE SQUELETTIQUE EN MUSCLE LENT | ||
| (54) Title (JA): 骨格筋遅筋化用組成物 | ||
|
|
||
| (57) Abstract: | ||
| (EN): Provided is a composition, e.g., a composition for converting skeletal muscle to slow muscle, that can be used for a specific purpose. A composition that contains Bifidobacterium bacteria as an active ingredient.
(FR): L'invention concerne une composition, par exemple une composition destinée à convertir un muscle squelettique en muscle lent, pouvant être utilisée à des fins spécifiques. L'invention concerne plus particulièrement une composition contenant comme principe actif des bactéries Bifidobacterium. (JA): 骨格筋遅筋化用組成物等の特定の用途に利用できる組成物を提供する。ビフィドバクテリウム(Bifidobacterium)属細菌を有効成分として含有する、組成物。 |
||
|
|
||
| International search report: | ||
| Received at International Bureau: 22 June 2020 (22.06.2020) [JP] | ||
|
|
||
| International Report on Patentability (IPRP) Chapter II of the PCT: | ||
| Not available | ||
|
|
||
| (81) Designated States: | ||
| AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, WS, ZA, ZM, ZW | ||
| European Patent Office (EPO) : AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | ||
| African Intellectual Property Organization (OAPI) : BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG | ||
| African Regional Intellectual Property Organization (ARIPO) : BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW | ||
| Eurasian Patent Organization (EAPO) : AM, AZ, BY, KG, KZ, RU, TJ, TM | ||
|
|
||